GNRH1 and breast carcinoma: In fact, hormones are associated with the metastasis risk of breast cancer and can be used as therapies for breast cancer [51], for example, progestin and GnRH are treatments for breast cancer patients [52], [53] and progesterone receptors are used as a prognostic factor in Stage II breast cancer [54].